PolyPid Ltd.
PYPD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001611842
No open-market purchases or sales by PolyPid Ltd. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $16.7M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +14 vs. previous quarter
- 33
- 13F valueReported value at the end of Q2 2026
- $16.7M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding PYPD, Q2 2026
No superinvestor reported holding PYPD at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by PolyPid Ltd. insiders from Form 4, newest first.
No open-market purchases or sales by PolyPid Ltd. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in PolyPid Ltd. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 1,504,741 | $7.64M | 0.69% | −88,846−5.6% | Reduced |
| Rosalind Advisors, Inc. | 389,455 | $1.98M | 0.74% | −208,471−34.9% | Reduced |
| DAFNA Capital Management LLC | 207,900 | $1.06M | 0.20% | 00.0% | Unchanged |
| Morgan Stanley | 123,136 | $625.5K | 0.00% | −53,756−30.4% | Reduced |
| Renaissance Technologies LLC | 116,619 | $592.4K | 0.00% | +98,023+527.1% | Added |
| Marshall Wace, LLP | 115,014 | $584.3K | 0.00% | +115,014 | New |
| ADAR1 Capital Management, LLC | 103,950 | $528.1K | 0.02% | 00.0% | Unchanged |
| Symmetry Peak Management LLC | 100,881 | $512.5K | 11.21% | +13,688+15.7% | Added |
| J. Goldman & Co LP | 99,183 | $503.9K | 0.02% | −50,316−33.7% | Reduced |
| Jane Street Group, LLC | 83,126 | $422.3K | 0.00% | +61,484+284.1% | Added |